GSK-110804

Study Sponsor: GSK

Study Title

Evaluation of GSK Biologicals’ dTpa booster vaccine in adults, given 10 years after previous dTpa boosting.

Medicine or Vaccine (generic name)

Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis Vaccine

Sponsor Identification Number

110804

Trial Registry Identification Number(#'s)

NCT00548171

Medical Condition

Acellular pertussis; Diphtheria; Tetanus

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013